How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

BS

NYSE:BSX
Get a brief AI stock analysisSaves ~ 15 minutes of your time

BS

Boston Scientific CorpNYSE BSX Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNYS - New York Stock Exchange, Inc

FAIR VALUE

Is BSX undervalued compared to its fair value?

The fair value of BSX stock is hidden USD. Relative to the market price of 78.59 USD Boston Scientific Corp is hidden.

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. The company is headquartered in Marlborough, Massachusetts and current...[More about valuation]

Boston Scientific Corp Fair Value

Available for registered user
UNLOCK
What is fair value?

Market cap:

115.07 $B

Price:

78.59 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

0.334

BSX stock is better priced for investment 20% of the companies in Healthсare sector
BSX stock is better priced for investment 25% of the companies on New York Stock Exchange, Inc Exchange

FINANCIALS

Boston Scientific Corp financial for reporting period

Income Statement

3.9 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.49 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

3.9 B 100%
2.7 B 69%
0.49 B 13%

Balance Sheet

36.7 B
19.9 B


Financial Position Analysis

Assets

36.7 B
Current Assets
8.2 B
Total non-current assets
28.5 B

Total current liabilities
4.9 B
Total non-current liabilities
11.8 B

Cash Flow Statement

1.6 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.16 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Boston Scientific Corp fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

9 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
7 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
5 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Boston Rating

Is BSX attractive for investment based on fundamental analysis?

BSX stock rating is hidden. Boston Scientific Corp is a hidden by Eyestock methodology.

Get BSX Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

12

Gross Margin:

69

CFO / Debt ratio:

hidden

Current ratio:

1.426

Debt / Equity ratio:

0.494

ROE:

9

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

BSX analysis by AI

Was this information helpful?

Eyebot AI analysis

The financial analysis of Boston Scientific Corp shows a mixed picture over the last four quarters. The company has been able to maintain a relatively stable gross margin around 70%, indicating efficient cost management. However, the net profit margin has been decreasing, which raises concerns about the company's profitability. The company's cash flow from operations to net income ratio has been consistently high, reflecting good quality earnings. On the other hand, the return on equity and return on invested capital have been low, suggesting inefficiencies in capital utilization. The company's current and equity ratios are slightly below the industry benchmarks, indicating some financial risk due to a higher level of debt. Additionally, the stability ratios over the past five years and two years have also been below the benchmarks, suggesting potential volatility in the company's performance. Finally, the price-to-earnings ratio is relatively high, which may indicate that the stock is overvalued. Overall, while the company shows some strengths such as maintaining a stable gross margin, there are also weaknesses in terms of decreasing profitability and financial risk. Investors should carefully assess these factors before making investment decisions.

Boston Scientific Corp dividends

BSX dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About BSX stock

About the company Boston Scientific Corp

Market cap $B

115.07

Dividend yield

Shares outstanding

1434.78 B

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. The company is headquartered in Marlborough, Massachusetts and currently employs 45,000 full-time employees. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy and Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions. Its Urology and Neuromodulation business develops and manufactures devices to treat various urological, neurological movement disorders and pelvic conditions. Its Cardiac Rhythm Management develops and manufactures a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment include Interventional Cardiology and Peripheral Interventions. Its Interventional Cardiology develops and manufactures technologies for diagnosing and treating coronary artery disease and structural heart conditions. Its product offerings include 360 Clips and RESONATE, among others.

BSX profile

  • Ticker

    BSX

  • Country

    USA

  • Exchange

    XNYS - New York Stock Exchange, Inc

  • Report currency

    USD - US dollar

  • IPO date

    19 May 1992

  • Sector

    Healthсare

  • Industry

    Health Care Equipment & Supplies

  • Employees

    45000

  • City

    Marlborough

  • Address

    300 Boston Scientific Way

  • Cusip

    101137107

Frequently Asked Questions

What sector does Boston operate in?

Boston operates in Healthсare sector

What is market cap of Boston?

Market cap of Boston is 115.07 USD as of 24 Jul 2024

What is market price of one BSX stock?

Market price of one BSX stock is 78.59 USD as of 24 Jul 2024

What is Boston revenue?

According to the recent report Boston revenue is 3856

What is Boston net income?

According to the recent report Boston net icnome is 495

What is Boston net income growh rate?

Net income growth rate of Boston is 61